Kyverna Therapeutics vs Vertex Pharmaceuticals: 2026 Buy Guide
In 2026, investors face a critical choice between a clinical-stage biotech and a cash-flow powerhouse. This guide com...
Identify which cash back rewards cards come with no annual fees. Maximize your rewards while saving on costs.
27,908 articlesIn 2026, investors face a critical choice between a clinical-stage biotech and a cash-flow powerhouse. This guide com...
The White House rejected Elon Musk’s public offer to fund TSA salaries during the budget stalemate, setting off a fre...
Iran faces a sharp economic decline after renewed conflict, with staple prices surging and millions at risk of povert...
Seagate Technology has rallied about 250% year-to-date as AI storage demand accelerates. This update weighs whether t...
The CLARITY Act moves toward a Senate floor vote, potentially codifying XRP’s regulatory status. This piece breaks do...
Antero Resources is attracting takeover chatter as major energy players weigh bids. With strong cash flow and LNG exp...
Icahn Enterprises just added a sizable stake in Centuri Holdings, signaling a continued conviction in North America's...
Johnson & Johnson shares jump as the company pushes through a resilient oncology lineup and strategic investments, li...
PTIR's double-leveraged bet on Palantir underperformed the stock by nearly half over the past year, underscoring the ...
As 2026 unfolds amid market swings and thinner savings, Suze Orman’s call to delay Social Security to 70 sharpens the...
The AI inference market could surge to about $255 billion by 2030 as demand for real-time AI services climbs. Learn w...
Oil prices jumped above $100 a barrel as YieldMax’s XOMO ETF continued to pay weekly distributions fed by option prem...